Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,833 | -195,625 | -213,391 | 9,586 | 14,722 |
| Depreciation Amortization | 49,555 | 57,365 | 55,398 | 34,875 | 28,643 |
| Income taxes - deferred | -5,394 | -2,377 | -46,658 | -9,756 | 644 |
| Accounts receivable | -10,666 | 10,055 | -17,672 | -20,052 | -3,941 |
| Other Working Capital | -11,780 | -3,181 | -29,730 | -15,145 | 15,308 |
| Other Operating Activity | 60,913 | 149,107 | 238,516 | 23,483 | 16,423 |
| Operating Cash Flow | $38,795 | $15,344 | $-13,537 | $22,991 | $71,799 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,006 | -7,362 | -1,478 | -13,520 | -16,579 |
| Net Acquisitions | 24,678 | 34,675 | N/A | -262,870 | N/A |
| Purchase Of Investment | -709 | N/A | -10,042 | -7,370 | -4,093 |
| Other Investing Activity | 0 | -11,506 | -104,916 | 0 | 172 |
| Investing Cash Flow | $22,963 | $15,807 | $-116,436 | $-283,760 | $-20,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 64,000 | 104,659 | 277,453 | 49,000 |
| Debt Repayment | -59,584 | -87,264 | -45,038 | -111,250 | -59,000 |
| Common Stock Issued | 2,442 | 778 | 5,822 | 109,410 | 0 |
| Dividend Paid | N/A | N/A | N/A | N/A | -19,886 |
| Other Financing Activity | 2,562 | -4,167 | -3,367 | -2,242 | 317 |
| Financing Cash Flow | $-54,580 | $-26,653 | $62,076 | $273,371 | $-29,569 |
| Exchange Rate Effect | -2,560 | 629 | 521 | -228 | 589 |
| Beginning Cash Position | 36,964 | 31,837 | 99,213 | 86,839 | 64,520 |
| End Cash Position | 41,582 | 36,964 | 31,837 | 99,213 | 86,839 |
| Net Cash Flow | $4,618 | $5,127 | $-67,376 | $12,374 | $22,319 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,795 | 15,344 | -13,537 | 22,991 | 71,799 |
| Capital Expenditure | -1,006 | -7,362 | -1,478 | -13,520 | -16,579 |
| Free Cash Flow | 37,789 | 7,982 | -15,015 | 9,471 | 55,220 |